Name: SYKES & RAY EQUITIES (I) LTD.
Address: 3rd Floor, Cama Building, Dalal St, Kala Ghoda, Fort, Mumbai, 400001, IN
Telephone: 022 6193 7300

Markets

Market Nav

BALANCE SHEET

You can view the balance sheet for the last 5 years.

Titan Biotech Ltd.

Aug 19 BSE 456.85 ( -5.75 -1.24%)

Volume2768

Prev. Close
462.60

Open Price
465.00

Today's Low / High

454.00 470.00

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

373.65 1017.85

Titan Biotech Ltd.is not traded in NSE

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	82.64	82.64	82.64	82.64	82.64

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	8.26	8.26	8.26	8.26	8.26
Total Share Capital	8.26	8.26	8.26	8.26	8.26

Reserves and Surplus	145.14	125.19	101.65	90.40	60.49
Total Reserves and Surplus	145.14	125.19	101.65	90.40	60.49
Total Shareholders Funds	153.40	133.45	109.91	98.67	68.76
Minority Interest	0.00	0.00	0.00	6.74	3.72

NON-CURRENT LIABILITIES
Long Term Borrowings	0.18	0.45	0.30	8.40	4.86
Deferred Tax Liabilities [Net]	1.52	1.37	1.21	1.31	1.39
Other Long Term Liabilities	0.23	0.69	1.13	1.55	1.40
Long Term Provisions	1.63	1.48	1.62	1.51	1.49
Total Non-Current Liabilities	3.57	4.00	4.25	12.76	9.13

CURRENT LIABILITIES
Short Term Borrowings	1.92	6.72	6.70	7.47	8.29
Trade Payables	5.22	3.37	5.55	7.55	3.71
Other Current Liabilities	9.97	8.48	7.77	9.92	7.11
Short Term Provisions	0.63	0.56	0.33	0.29	0.00
Total Current Liabilities	17.74	19.13	20.35	25.23	19.11

Total Capital And Liabilities	174.71	156.58	134.52	143.40	100.72

ASSETS
NON-CURRENT ASSETS
Tangible Assets	57.18	51.94	35.81	42.05	33.51
Intangible Assets	0.11	0.07	0.09	0.10	0.09
Capital Work-In-Progress	1.68	2.53	13.29	7.97	0.27
Intangible Assets Under Development	0.00	0.02	0.00	0.00	0.00
Fixed Assets	58.97	54.56	49.19	50.12	33.88
Non-Current Investments	32.77	28.19	15.41	0.00	0.00
Other Non-Current Assets	3.93	1.65	1.62	1.93	7.51
Total Non-Current Assets	95.67	84.41	66.21	52.05	41.39


CURRENT ASSETS
Inventories	50.72	45.57	36.17	42.29	32.54
Trade Receivables	18.82	18.66	21.01	21.67	18.10
Cash And Cash Equivalents	5.56	2.84	4.86	15.61	5.63
OtherCurrentAssets	3.94	5.11	6.26	11.78	3.05
Total Current Assets	79.04	72.17	68.31	91.35	59.33

Total Assets	174.71	156.58	134.52	143.40	100.72

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00	12.90	1.13	3.20	0.38

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.00	28.19	15.41	0.00	0.00

Particulars	Mar 25
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR
FaceValue	10.00
No. of Equity Shares (in Lacs)	82.64

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	8.26
Total Share Capital	8.26
Reserves and Surplus	145.14
Total Reserves and Surplus	145.14
Total Shareholders Funds	153.40
Minority Interest	0.00
NON-CURRENT LIABILITIES
Long Term Borrowings	0.18
Deferred Tax Liabilities [Net]	1.52
Other Long Term Liabilities	0.23
Long Term Provisions	1.63
Total Non-Current Liabilities	3.57
CURRENT LIABILITIES
Short Term Borrowings	1.92
Trade Payables	5.22
Other Current Liabilities	9.97
Short Term Provisions	0.63
Total Current Liabilities	17.74
Total Capital And Liabilities	174.71
ASSETS
NON-CURRENT ASSETS
Tangible Assets	57.18
Intangible Assets	0.11
Capital Work-In-Progress	1.68
Intangible Assets Under Development	0.00
Fixed Assets	58.97
Non-Current Investments	32.77
Other Non-Current Assets	3.93
Total Non-Current Assets	95.67
CURRENT ASSETS
Inventories	50.72
Trade Receivables	18.82
Cash And Cash Equivalents	5.56
OtherCurrentAssets	3.94
Total Current Assets	79.04
Total Assets	174.71
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00
NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.00